STOCK TITAN

[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 filing overview: On 06/30/2025, Post Holdings, Inc. (POST) director Jennifer Kuperman Johnson acquired an additional 101.906 Post stock equivalents under the company’s Deferred Compensation Plan for Non-Management Directors. The acquisition, coded “A,” was effected at a reference price of $109.03 per equivalent share. Following the credit, the reporting person now holds 5,794.335 stock equivalents, all reported as direct beneficial ownership. The stock equivalents have no fixed vesting or expiration dates and are distributed in cash, one-for-one, upon the director’s separation from the Board.

No open-market purchase or sale of common stock occurred; the transaction solely reflects routine deferral of board retainers into equity equivalents. There were no non-derivative transactions disclosed in Table I.

Panoramica della presentazione del Modulo 4: Il 30/06/2025, Jennifer Kuperman Johnson, direttrice di Post Holdings, Inc. (POST), ha acquisito ulteriori 101,906 equivalenti azionari di Post nell'ambito del Piano di Compensazione Differita per i Direttori Non-Manageriali della società. L'acquisizione, contrassegnata con il codice “A,” è stata effettuata a un prezzo di riferimento di 109,03 $ per azione equivalente. Dopo l'accredito, la persona segnalante detiene ora 5.794,335 equivalenti azionari, tutti riportati come proprietà beneficiaria diretta. Gli equivalenti azionari non hanno date fisse di maturazione o scadenza e vengono liquidati in contanti, uno a uno, al momento della separazione del direttore dal Consiglio.

Non si sono verificate operazioni di acquisto o vendita sul mercato aperto di azioni ordinarie; la transazione riflette esclusivamente il differimento ordinario dei compensi del consiglio in equivalenti azionari. Non sono state divulgate transazioni non derivate nella Tabella I.

Resumen de la presentación del Formulario 4: El 30/06/2025, Jennifer Kuperman Johnson, directora de Post Holdings, Inc. (POST), adquirió 101,906 equivalentes de acciones adicionales de Post bajo el Plan de Compensación Diferida para Directores No Gerenciales de la empresa. La adquisición, codificada como “A,” se realizó a un precio de referencia de $109.03 por acción equivalente. Tras el crédito, la persona informante ahora posee 5,794.335 equivalentes de acciones, todos reportados como propiedad beneficiosa directa. Los equivalentes de acciones no tienen fechas fijas de adquisición ni de vencimiento y se distribuyen en efectivo, uno a uno, al separarse el director del Consejo.

No se realizó ninguna compra o venta en el mercado abierto de acciones comunes; la transacción refleja únicamente un diferimiento rutinario de las retenciones del consejo en equivalentes de acciones. No se divulgaron transacciones no derivadas en la Tabla I.

Form 4 제출 개요: 2025년 6월 30일, Post Holdings, Inc.(POST)의 이사 Jennifer Kuperman Johnson은 회사의 비경영 이사 대상 이연 보상 계획에 따라 추가로 101.906 주식 등가물을 취득했습니다. “A” 코드로 표시된 이번 취득은 주당 $109.03의 기준 가격으로 이루어졌습니다. 해당 적립 후 보고자는 현재 총 5,794.335 주식 등가물을 보유하고 있으며, 모두 직접 실질 소유로 신고되었습니다. 주식 등가물은 고정된 권리 취득일이나 만료일이 없으며, 이사가 이사회에서 물러날 때 1대1 현금으로 지급됩니다.

공개 시장에서의 보통주 매매는 발생하지 않았으며, 이번 거래는 이사회 보수의 주식 등가물로의 일상적인 이연만을 반영합니다. 표 I에는 비파생 거래가 공개되지 않았습니다.

Présentation générale du dépôt du Formulaire 4 : Le 30/06/2025, Jennifer Kuperman Johnson, administratrice de Post Holdings, Inc. (POST), a acquis 101,906 équivalents d’actions Post supplémentaires dans le cadre du Plan de Compensation Différée pour les Administrateurs Non-Exécutifs de la société. L’acquisition, codée « A », a été réalisée à un prix de référence de 109,03 $ par action équivalente. Après ce crédit, la personne déclarant détient désormais 5 794,335 équivalents d’actions, tous déclarés en tant que propriété bénéficiaire directe. Ces équivalents d’actions n’ont pas de dates fixes d’acquisition ni d’expiration et sont versés en espèces, au taux de un pour un, lors de la séparation de l’administrateur du Conseil.

Aucun achat ou vente d’actions ordinaires sur le marché ouvert n’a eu lieu ; la transaction reflète uniquement un report de rémunération du conseil en équivalents d’actions. Aucune transaction non dérivée n’a été divulguée dans le Tableau I.

Übersicht der Form 4 Einreichung: Am 30.06.2025 erwarb Jennifer Kuperman Johnson, Direktorin von Post Holdings, Inc. (POST), weitere 101,906 Aktienäquivalente von Post im Rahmen des Deferred Compensation Plans für nicht-geschäftsführende Direktoren des Unternehmens. Der Erwerb, mit dem Code „A“ gekennzeichnet, erfolgte zu einem Referenzpreis von 109,03 $ pro Aktienäquivalent. Nach der Gutschrift hält die meldende Person nun insgesamt 5.794,335 Aktienäquivalente, alle als direkter wirtschaftlicher Eigentum ausgewiesen. Die Aktienäquivalente haben keine festen Vesting- oder Verfallsdaten und werden bei Ausscheiden des Direktors aus dem Vorstand eins zu eins in bar ausgezahlt.

Es fanden keine Käufe oder Verkäufe von Stammaktien am offenen Markt statt; die Transaktion spiegelt ausschließlich die routinemäßige Umwandlung von Vorstandsvergütungen in Aktienäquivalente wider. In Tabelle I wurden keine nicht-derivativen Transaktionen offengelegt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine deferral; immaterial to POST valuation.

The filing records a standard quarterly retainer deferral of 101.906 stock equivalents into the director’s account. The dollar value (~$11k) is negligible relative to Post’s market capitalization and trading volume. Because the shares are not actually issued and will be settled in cash upon board departure, there is no dilution impact and limited signaling value. Investors should view this as administrative rather than a directional bet on the stock.

TL;DR: Signals continued alignment; no governance red flags.

Deferred share equivalents keep director compensation tied to equity performance, reinforcing alignment with shareholders. The absence of Rule 10b5-1 designation and the small size mean insider-sentiment conclusions are weak. Overall governance posture remains conventional and benign.

Panoramica della presentazione del Modulo 4: Il 30/06/2025, Jennifer Kuperman Johnson, direttrice di Post Holdings, Inc. (POST), ha acquisito ulteriori 101,906 equivalenti azionari di Post nell'ambito del Piano di Compensazione Differita per i Direttori Non-Manageriali della società. L'acquisizione, contrassegnata con il codice “A,” è stata effettuata a un prezzo di riferimento di 109,03 $ per azione equivalente. Dopo l'accredito, la persona segnalante detiene ora 5.794,335 equivalenti azionari, tutti riportati come proprietà beneficiaria diretta. Gli equivalenti azionari non hanno date fisse di maturazione o scadenza e vengono liquidati in contanti, uno a uno, al momento della separazione del direttore dal Consiglio.

Non si sono verificate operazioni di acquisto o vendita sul mercato aperto di azioni ordinarie; la transazione riflette esclusivamente il differimento ordinario dei compensi del consiglio in equivalenti azionari. Non sono state divulgate transazioni non derivate nella Tabella I.

Resumen de la presentación del Formulario 4: El 30/06/2025, Jennifer Kuperman Johnson, directora de Post Holdings, Inc. (POST), adquirió 101,906 equivalentes de acciones adicionales de Post bajo el Plan de Compensación Diferida para Directores No Gerenciales de la empresa. La adquisición, codificada como “A,” se realizó a un precio de referencia de $109.03 por acción equivalente. Tras el crédito, la persona informante ahora posee 5,794.335 equivalentes de acciones, todos reportados como propiedad beneficiosa directa. Los equivalentes de acciones no tienen fechas fijas de adquisición ni de vencimiento y se distribuyen en efectivo, uno a uno, al separarse el director del Consejo.

No se realizó ninguna compra o venta en el mercado abierto de acciones comunes; la transacción refleja únicamente un diferimiento rutinario de las retenciones del consejo en equivalentes de acciones. No se divulgaron transacciones no derivadas en la Tabla I.

Form 4 제출 개요: 2025년 6월 30일, Post Holdings, Inc.(POST)의 이사 Jennifer Kuperman Johnson은 회사의 비경영 이사 대상 이연 보상 계획에 따라 추가로 101.906 주식 등가물을 취득했습니다. “A” 코드로 표시된 이번 취득은 주당 $109.03의 기준 가격으로 이루어졌습니다. 해당 적립 후 보고자는 현재 총 5,794.335 주식 등가물을 보유하고 있으며, 모두 직접 실질 소유로 신고되었습니다. 주식 등가물은 고정된 권리 취득일이나 만료일이 없으며, 이사가 이사회에서 물러날 때 1대1 현금으로 지급됩니다.

공개 시장에서의 보통주 매매는 발생하지 않았으며, 이번 거래는 이사회 보수의 주식 등가물로의 일상적인 이연만을 반영합니다. 표 I에는 비파생 거래가 공개되지 않았습니다.

Présentation générale du dépôt du Formulaire 4 : Le 30/06/2025, Jennifer Kuperman Johnson, administratrice de Post Holdings, Inc. (POST), a acquis 101,906 équivalents d’actions Post supplémentaires dans le cadre du Plan de Compensation Différée pour les Administrateurs Non-Exécutifs de la société. L’acquisition, codée « A », a été réalisée à un prix de référence de 109,03 $ par action équivalente. Après ce crédit, la personne déclarant détient désormais 5 794,335 équivalents d’actions, tous déclarés en tant que propriété bénéficiaire directe. Ces équivalents d’actions n’ont pas de dates fixes d’acquisition ni d’expiration et sont versés en espèces, au taux de un pour un, lors de la séparation de l’administrateur du Conseil.

Aucun achat ou vente d’actions ordinaires sur le marché ouvert n’a eu lieu ; la transaction reflète uniquement un report de rémunération du conseil en équivalents d’actions. Aucune transaction non dérivée n’a été divulguée dans le Tableau I.

Übersicht der Form 4 Einreichung: Am 30.06.2025 erwarb Jennifer Kuperman Johnson, Direktorin von Post Holdings, Inc. (POST), weitere 101,906 Aktienäquivalente von Post im Rahmen des Deferred Compensation Plans für nicht-geschäftsführende Direktoren des Unternehmens. Der Erwerb, mit dem Code „A“ gekennzeichnet, erfolgte zu einem Referenzpreis von 109,03 $ pro Aktienäquivalent. Nach der Gutschrift hält die meldende Person nun insgesamt 5.794,335 Aktienäquivalente, alle als direkter wirtschaftlicher Eigentum ausgewiesen. Die Aktienäquivalente haben keine festen Vesting- oder Verfallsdaten und werden bei Ausscheiden des Direktors aus dem Vorstand eins zu eins in bar ausgezahlt.

Es fanden keine Käufe oder Verkäufe von Stammaktien am offenen Markt statt; die Transaktion spiegelt ausschließlich die routinemäßige Umwandlung von Vorstandsvergütungen in Aktienäquivalente wider. In Tabelle I wurden keine nicht-derivativen Transaktionen offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
D'Alessandro Danilo

(Last) (First) (Middle)
C/O CLEARPOINT NEURO, INC.
120 S. SIERRA AVE., SUITE 100

(Street)
SOLANA BEACH CA 92075

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ClearPoint Neuro, Inc. [ CLPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/30/2025 A 376 A $10.15(1) 66,368 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2025 through June 30, 2025. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.
/s/ Danilo D'Alessandro 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Post Holdings (POST) stock equivalents did the director acquire?

Jennifer Kuperman Johnson acquired 101.906 stock equivalents on 06/30/2025.

What is the total number of stock equivalents the director now holds?

After the transaction, she beneficially owns 5,794.335 Post stock equivalents.

Was this an open-market trade of POST common shares?

No. The filing reflects a deferred compensation credit, not a market purchase or sale.

Does the transaction have an exercisable or expiration date?

No. The stock equivalents carry no fixed exercisable or expiration dates.

Will these stock equivalents dilute existing shareholders?

No. They are settled in cash and do not result in new share issuance.
Clearpoint Neuro Inc

NASDAQ:CLPT

CLPT Rankings

CLPT Latest News

CLPT Latest SEC Filings

CLPT Stock Data

339.75M
25.90M
8.01%
33.26%
2.62%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SOLANA BEACH